Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects
Nora Klöting(Helmholtz Centre for Environmental Research), Matthias Blüher(Helmholtz Centre for Environmental Research), Mathias Faßhauer(Center for Clinical Research (United States)), Annette G. Beck‐Sickinger(Leipzig University), John T. Heiker(Helmholtz Centre for Environmental Research), Michael P. Schön(Universitätsmedizin Göttingen), Matthias Kern(Unknown), Péter Kovács, Michael Stümvoll(University Hospital Leipzig)
Cited by 155
Related Papers
Retinol-Binding Protein 4 and Insulin Resistance in Lean, Obese, and Diabetic Subjects
|New England Journal of Medicine|2006|1.3k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Metabolically Healthy Obesity
|Endocrine Reviews|2020|995